Home / Business and Economy / US FDA Greenlights 200+ Products for Indian Manufacturer
US FDA Greenlights 200+ Products for Indian Manufacturer
27 Oct
Summary
- Asia's first company with over 200 US FDA registered surgical products.
- Silvassa manufacturing expansion completed ahead of schedule.
- Exports to the US planned for December 2026, eyeing South America.
Lord's Mark Industries has announced the completion of its Silvassa manufacturing capacity expansion ahead of schedule. This strategic development positions the company to significantly expand its international presence. It is Asia's first company to secure US FDA registration for more than 200 surgical, medical-care, and hygiene products.
The company is set to commence exports to the United States in December 2026. Concurrently, Lord's Mark Industries is preparing to explore market opportunities across South America, subject to local regulatory approvals.
With a comprehensive product portfolio including orthopaedic supports, mobility solutions, and hygiene essentials, the company aims to establish a robust export business from India. This expansion is crucial as the US general surgical devices market is projected to grow to US$9.67 billion by 2031, and South America's market is expected to reach US$2.19 billion by 2031.
